INTRODUCTION: High blood pressure (HBP) is an independent, modifiable driver of cardiovascular (CV) morbidity and mortality. Nocturnal hypertension and non-dipping of blood pressure (NdBP) may be early markers of HBP. Similar to patients with NdBP, individuals with non-dipping of heart rate (NdHR) during sleep have an increased risk of CV disease, CV events, and CV-related mortality. The aim of this analysis was to evaluate if cardiopulmonary coupling (CPC) analysis-derived sleep states [stable/unstable non-rapid eye movement (NREM) sleep] and concomitant heart rate (HR) changes can provide information about nocturnal blood pressure (BP).
METHOD: Plethysmogram (pleth) signals from the HeartBEAT study (NCT01086800) were analyzed for CPC sleep states. Included in the analysis are sleep recordings from participants with acceptable pleth-signal quality at baseline (n = 302) and follow-up (n = 267), all having confirmed CV disease or CV-disease risk factors. The participants had a high prevalence of obstructive sleep apnea (OSA), 98.4% with moderate-OSA [apnea-hypopnea index (AHI) ≥ 15) and 29.6% severe OSA (AHI ≥ 30). A "heart-rate module" was created to evaluate the utility of identifying patients more likely to have BP dipping during sleep. Patients who did not have a decrease of ≥10% in their BP from wake to sleep were defined as NdBP and NdHR if their heart rate during stable-NREM sleep was higher than during unstable-NREM sleep.
RESULTS: The most significant difference in minimum HR (HRmin) was observed when comparing BP dippers [56 ± 4 beats per minute (BPM)] and non-BP dippers (59 ± 4 BPM; p < 0.0001) during diastolic blood pressure in stable-NREM sleep. Higher HRmin were associated with an increased likelihood of being a non-dipper, with the strongest relationship with diastolic BP and stable-NREM sleep. Every increase of 1 BPM during stable-NREM sleep was associated with an 4.4% increase in the probability of NdBP (p = 0.001). Subjects with NdHR have higher mean BP during sleep and wake periods than HR dippers. When continuous positive airway pressure therapy is efficacious, and a dipping pattern is achieved-physical and mental health is improved.
CONCLUSION: HR analytics in relation to the sleep period and the CPC spectrogram-estimated sleep states can provide novel and potentially clinically useful information on autonomic health. HR dipping (or not) may be a useful screener of BP dipping or non-dipping to identify individuals who may benefit from a formal assessment of 24-h ambulatory BP. Such a stepped approach may enable a more practical and applicable approach to diagnosing HBP.
CLINICAL TRIAL REGISTRATION: The Heart Biomarker Evaluation in Apnea Treatment (HeartBEAT) study is registered at clinicaltrials.gov/ct2/show/NCT01086800.